NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
October 23, 2007 • Volume 4 / Number 28 E-Mail This Document  |  View PDF Version  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Decline in Cancer Death Rate Accelerating

Director's Update
With caBIG, the Cancer Community Goes "Interoperable"

Cancer Research Highlights
Trials Demonstrate Potential Role of HPV Screening Test

More Genetic Markers Found for Prostate Cancer Risk

Paclitaxel Benefit May Depend on HER2 Status

Batracylin Blocks DNA Replication in Cancer Cells

Special Report
Preventive Double Mastectomies Increasing Despite Some Concerns

FDA Update
New Chemotherapy Drug for Advanced Breast Cancer

Guest Commentary
Strengthening the Nation's Oncology Workforce

Featured Clinical Trial
Preventing Delayed Nausea in Breast Cancer Patients

Funding Opportunities

Notes
DCLG to Meet October 24-25

PLCO Etiology Study Seeks Applicants

YMCA and Armstrong Foundation Partner to Promote Wellness for Cancer Survivors

NCI Liaison Office Launches Web Site

New Patient Education Materials Available

Disparities Summit Report Available

NCI 70th Anniversary: If Memory Serves...

Cancer Center Profile
Case Comprehensive Cancer Center

Bulletin Archive

About the Bulletin

Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
Notes

70 Years of Excellence in Cancer Research

If Memory Serves...

After NCI began funding research proposals in 1937, there was a strict policy of separation between intramural and extramural projects. This was, in part, to avoid criticism that intramural personnel could benefit from knowledge of extramural grant requests. (Read more)

For more information about the birth of NCI, go to http://www.cancer.gov/
aboutnci/ncia
.

DCLG to Meet October 24-25
The NCI Director's Consumer Liaison Group (DCLG) will meet on October 24-25 in Room 6C10 in Building 31 on the NIH campus in Bethesda, MD. The meeting is open to the public and public comments will be accepted at 3:15 p.m. on October 25. The meeting will be webcast at http://videocast.nih.gov; the agenda is available at http://deainfo.nci.nih.gov/advisory/dclg/24oct07adg.pdf.

PLCO Etiology Study Seeks Applicants
The Etiology and Early Marker Studies (EEMS) is a component of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. By collecting biologic materials and risk factor information from trial participants before the diagnosis of disease, PLCO EEMS provides a resource for cancer research, focused on cancer etiology and early markers. Etiologic studies investigate the environmental, biochemical, and genetic risk factors for cancer. Early detection studies aim to develop reproducible, diagnostics-ready biomarkers of early disease.

PLCO data and biospecimens are available to qualified researchers through a peer review process. The EEMS program accepts proposals for access to PLCO biospecimens twice a year in June and December. Proposals will be accepted for the PLCO EEMS winter review cycle starting December 1, 2007. Applications will be accepted until December 28, 2007 at 5:00 p.m., ET. Details of the review process and application materials are available at http://www.parplco.org.

YMCA and Armstrong Foundation Partner to Promote Wellness for Cancer Survivors
The YMCA of the USA and the Lance Armstrong Foundation recently announced a partnership to develop physical activity and well-being initiatives to address the specific needs, wants, and interests of cancer survivors. During the pilot and implementation phases of the project, a panel of cancer survivorship researchers, including NCI representatives, will contribute their knowledge and perspective on best practices.

NCI Liaison Office Launches Web Site
The NCI Liaison Office in Brussels, Belgium, recently launched a new Web site, making it easier for European cancer researchers to register clinical trials in PDQ, NCI's clinical trials registry.

The Liaison Office acts as a European link to NCI's cancer research and treatment programs. The mission of the office is to facilitate the interchange of information, ideas, experimental drugs, scientists, and scientific expertise between the NCI and its European partners and collaborating institutions. Activities include organization of joint symposia, initiation and coordination of exchange programs, launching of a joint clinical monitoring program, and an agreement with the European Organization for Research and Treatment of Cancer to coordinate submission of clinical trials to PDQ.

New Patient Education Materials Available
Six new or revised patient education publications are now available from NCI. They can be accessed, downloaded, or ordered at https://cissecure.nci.nih.gov/ncipubs/ or 1-800-4-CANCER. The new publications include: Chemotherapy and You; Radiation Therapy and You; Radiation Therapy Fact Sheet Series; Helping Providers Help Their Patients: Using the Radiation Therapy Fact Sheets; Caring for the Caregiver: Support for Cancer Caregivers; and Facing Forward: Life After Cancer Treatment. All of the materials are free; a shipping charge will be applied to orders of more than 20 total items.

Disparities Summit Report Available
NCI's Center to Reduce Cancer Health Disparities and the National Center on Minority Health and Health Disparities recently released the report on the Cancer Health Disparities Summit 2006, Strengthening Our Culture of Collaborations for Reducing Cancer Health Disparities. The report evolved from a 3-day workshop held July 17-19, 2006 and can be accessed and downloaded at http://www.cancermeetings.org/CHDSummit06/CHDStrengtheningReport.pdf.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov